ES8405394A1 - Un procedimiento para preparar derivados de imidazolina. - Google Patents

Un procedimiento para preparar derivados de imidazolina.

Info

Publication number
ES8405394A1
ES8405394A1 ES521440A ES521440A ES8405394A1 ES 8405394 A1 ES8405394 A1 ES 8405394A1 ES 521440 A ES521440 A ES 521440A ES 521440 A ES521440 A ES 521440A ES 8405394 A1 ES8405394 A1 ES 8405394A1
Authority
ES
Spain
Prior art keywords
imidazoline derivatives
phenethyl
hydroxyalkyl
allyl
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521440A
Other languages
English (en)
Other versions
ES521440A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Publication of ES8405394A1 publication Critical patent/ES8405394A1/es
Publication of ES521440A0 publication Critical patent/ES521440A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lock And Its Accessories (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Paper (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE IMIDAZOLINA.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN EQUIVALENTE MOLAR DE ETILENDIAMINA Y UN ALCOHOL DE FORMULA ROH, PARA OBTENER DERIVADOS DE IMIDAZOLINA DE FORMULA (I), DONDE R ES ALCOHILO DE C 1 A 4, ALILO, BENCILO, FENETILO, O HIDROXIALCOHILO DE C 2 A 4; HX ES UN ACIDO TAL COMO CLORURO DE HIDROGENO; Y R ES ALCOHILO DE C 1 A 4. LA REACCION SE REALIZA A TEMPERATURA EN EL INTERVALO DE 0-25JC Y EN PRESENCIA DE UN DISOLVENTE TAL COMO ALCOHOL DE FORMULA ROH.TIENE APLICACION, POR PRESENTARACTIVIDAD ANTAGONISTA DEL ALFA2-ADRENORRECEPTOR, PARA EL TRATAMIENTO DE LA DEPRESION.
ES521440A 1982-04-17 1983-04-14 Un procedimiento para preparar derivados de imidazolina. Granted ES521440A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8211205 1982-04-17

Publications (2)

Publication Number Publication Date
ES8405394A1 true ES8405394A1 (es) 1984-06-01
ES521440A0 ES521440A0 (es) 1984-06-01

Family

ID=10529762

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521440A Granted ES521440A0 (es) 1982-04-17 1983-04-14 Un procedimiento para preparar derivados de imidazolina.

Country Status (24)

Country Link
US (1) US4446148A (es)
EP (1) EP0092328B1 (es)
JP (1) JPS58192882A (es)
AT (1) ATE27275T1 (es)
AU (1) AU552397B2 (es)
CA (1) CA1190932A (es)
CS (1) CS233746B2 (es)
DD (1) DD209628A5 (es)
DE (1) DE3371631D1 (es)
DK (1) DK160093C (es)
ES (1) ES521440A0 (es)
FI (1) FI73676C (es)
GB (1) GB2118548B (es)
GR (1) GR78528B (es)
HU (1) HU190894B (es)
IE (1) IE54922B1 (es)
IL (1) IL68318A (es)
NO (1) NO158019C (es)
NZ (1) NZ203680A (es)
PL (1) PL143658B1 (es)
PT (1) PT76558B (es)
SU (1) SU1217257A3 (es)
ZA (1) ZA832278B (es)
ZW (1) ZW8783A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
AU6307690A (en) * 1989-09-27 1991-04-11 Rhone-Poulenc Sante Imidazoles
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
FR2766824B1 (fr) * 1997-07-30 1999-09-10 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
CS233746B2 (en) 1985-03-14
EP0092328A2 (en) 1983-10-26
EP0092328A3 (en) 1985-05-08
IL68318A0 (en) 1983-07-31
IE830858L (en) 1983-10-17
NO158019B (no) 1988-03-21
PL143658B1 (en) 1988-03-31
EP0092328B1 (en) 1987-05-20
DK160093B (da) 1991-01-28
JPS58192882A (ja) 1983-11-10
FI831199L (fi) 1983-10-18
US4446148A (en) 1984-05-01
ES521440A0 (es) 1984-06-01
HU190894B (en) 1986-12-28
AU1329883A (en) 1983-10-20
GR78528B (es) 1984-09-27
NZ203680A (en) 1985-08-16
NO831318L (no) 1983-10-18
ZW8783A1 (en) 1983-07-06
IL68318A (en) 1986-07-31
FI73676C (fi) 1987-11-09
DK163783D0 (da) 1983-04-14
FI73676B (fi) 1987-07-31
ATE27275T1 (de) 1987-06-15
DE3371631D1 (de) 1987-06-25
SU1217257A3 (ru) 1986-03-07
PL241515A1 (en) 1984-07-30
ZA832278B (en) 1983-12-28
DD209628A5 (de) 1984-05-16
GB2118548B (en) 1985-07-31
CA1190932A (en) 1985-07-23
GB2118548A (en) 1983-11-02
AU552397B2 (en) 1986-05-29
DK163783A (da) 1983-10-18
PT76558B (en) 1986-01-21
NO158019C (no) 1988-06-29
JPH0427984B2 (es) 1992-05-13
FI831199A0 (fi) 1983-04-11
PT76558A (en) 1983-05-01
IE54922B1 (en) 1990-03-28
DK160093C (da) 1991-06-24

Similar Documents

Publication Publication Date Title
ES8307796A1 (es) Un procedimiento para la preparacion de derivados de imidazolina.
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
ES8405394A1 (es) Un procedimiento para preparar derivados de imidazolina.
IE820209L (en) Imidazoline derivatives
DK407885A (da) 7-(2-(dialkylamino)ethyl)-4-hydroxy-1,3-benzimidazol-2-oner
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
GB1480892A (en) 3-nitropyrazole derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20011110